Related Experiment Video

Updated: Aug 9, 2026

Endolymphatic Duct Blockage as a Surgical Treatment Option for Ménière's Disease
04:11

Endolymphatic Duct Blockage as a Surgical Treatment Option for Ménière's Disease

Published on: April 28, 2023

Ménière's disease review 2005

George A Gates1

  • 1Department of Otolaryngology and Head and Neck Surgery, University of Washington, Seattle, WA 98195, USA. ggates@u.washington.edu

Journal of the American Academy of Audiology
|April 28, 2006
PubMed

Insights

Ménière's disease (MD) is an inner ear disorder causing vertigo and hearing loss. While vertigo often resolves, hearing loss in MD patients may be permanent.

Area of Science:

  • Otolaryngology
  • Neurology
  • Inner Ear Disorders

Background:

  • Ménière's disease (MD) is a common cause of episodic vertigo and fluctuating hearing loss.
  • Its etiology and pathophysiology remain incompletely understood despite extensive research.
  • Challenges include the lack of a validated clinical test, animal model, and specific treatment.

Purpose of the Study:

  • To review the current understanding of Ménière's disease.
  • To discuss the challenges in diagnosing and treating MD.
  • To provide an overview of management strategies for MD patients.

Main Methods:

  • Review of existing literature on Ménière's disease.
  • Analysis of diagnostic criteria and therapeutic approaches.
  • Synthesis of information regarding prognosis and patient management.

Main Results:

  • MD is characterized by episodic vertigo and fluctuating hearing loss.
  • The underlying causes and mechanisms of MD are still debated.
  • Symptom-specific treatments can manage MD, but hearing loss may be progressive.

Conclusions:

  • Effective management of Ménière's disease relies on tailored, symptom-specific therapies.
  • While vertigo prognosis is generally good, hearing loss in MD patients requires careful monitoring and management.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...